Adjunctive Cancer Care

Repurposed drugs and nutraceutical supplements, and metabolic interventions for the treatment of cancer

Improvement in 5-year cancer survival rates over the last 25 years

Months of improvement in overall survival from new cancer therapies over the last 15 years

About Adjunctive Cancer Care

A 25 year set of data from the U.S. indicated that 5-year cancer survival rates have only increased by 5% (63% to 68%). This is in spite of the fact that many billions have been poured into cancer research. For all these billions spent, the improvement in overall survival by new cancer therapies is just 2.4 months over the last 15 years (Ladanie et al). Over the last 30 years, another study reports an improvement of 3.4 months (Del Paggio et al).

The above statistics demonstrate an urgent need to identify more effective therapies, that come at less expense and have lower toxicity profiles than what traditional care is offering. So, our practice has worked in conjunction with Dr. Paul Marik to deliver adjunctive cancer care to any cancer patient that wants to seek out this type of care. The result of our partnership is a care program that uses repurposed pharmaceutical drugs and nutraceutical supplements, as well as metabolic/lifestyle interventions to treat cancer.

Unlike traditional care, our program sets to target a major root cause of cancer – metabolic dysfunction – based upon the research of Otto Warburg, Thomas Seyfriend, and many more. While chemo and radiation do not target Cancer Stem Cells, our therapies do. While chemo and radiation are cytotoxic and indiscriminate in the cells they target, our therapies support healthy cells while targeting cancerous ones.

On this page, you will find more information about our care model and costs, our treatment approaches, patient experiences via testimonials, answers to frequently asked questions, and additional resources.

Become A Patient - No Matter Where You Are Located

To become a patient of Leading Edge Clinic, you must first register. Registration does not require a monetary commitment, and allows us to reach out to interested patients who may have questions about our care model, treatment modalities, etc…

Operating under the legal framework of the First Nations Medical Board allows us to see patients in all 50 states. More information about the First Nations Medical Board can be found under the “General Practice” section of our FAQ page

Enroll For Treatment

Frequently Asked Questions

Can I still do traditional oncological treatments with your program?

Of course you can. The word “adjunctive” implies that this program is added to something else (ie: traditional treatment). Studies show that repurposed drugs actually help improve the outcomes of chemo and radiation treatments. For example, some Ivermectin studies, like this one, show it can reverse multi-drug resistance of cancer to chemo treatments. We will, of course, continue to monitor for possible drug and supplement interactions as your oncologist makes changes to your traditional treatments.

For more information about the synergistic effects of our program, with traditional onology treatments, please consult Dr. Marik’s book

Do I have to continue traditional treatments with your program?

No, you do not have to participate in traditional cancer treatments, if you do not want to. We have patients who make an informed decision to only pursue the use of repurposed drugs, nutraceutical supplements, and metabolic interventions. We also have patients who have exhausted all their options with traditional treatments. We highly recommend doing your due diligence when making this decision. As mentioned in the above FAQ answer, many of our treatments enhance the outcomes of traditional oncological standard of care.

What does care consist of?

The goal of care is to starve cancer cells by eliminating their fuel sources, kill cancer stem cells, interrupt certain cell signaling pathways of cancer (ie: angiogensis, cell division), and induce cancer cell apoptosis. We do this using a combination of repurposed drugs, repurposed nutraceutical supplements, and metabolic interventions. To learn more about some of these therapies, their pharmacological mechanisms of action, and the supporting studies, please refer to Dr. Marik’s cancer care book. Most of our care is based off of his Tier 1 and Tier 2 recommendations. However, we do employ some tactics that may fall outside of this scope.

Do you replace my oncologist?

No. We are not oncologists. We are MDs and FNPs working with the research available to us to give cancer patients their best shot at disease resolution. We do not have the capabilities of an oncology office (ie: delivering standard of care treatments). If possible, we do recommend finding an integrative oncologist that is amenable to adjunctive modalities of care.

How can I convince my oncologist that this treatment is right for me?

Dr. Marik’s cancer care book is an amalgamation of research that has been done on various repurposed drugs, nutraceutical supplements, and metabolic interventions. It a gold-mine for scientific study. It contains the references to help demonstrate to your oncologist why these therapies are both effective and safe, and therefore should be part of your cancer treatment plan.

We understand that even in the face of hard evidence, some providers will still reject these therapies. That is why it is important to find an oncologist with an open mind, and a willingness to challenge their own pre-conceived understanding of things. Integrative oncologists tend to be anyone’s best bet.

How long will I be on treatment?

Patients can expect to be on some repurposed drugs for a year minimum, even if cancer goes into remission. Another thing to consider is that metabolic dysfunction and disease, which create the environment for cancer proliferation, are progressive in nature. Patients should continue to make healthy metabolic decisions well after they receive news of remission, so as to not re-create the environment in which cancer can arise and thrive.

Are you offering a cure?

In the world of metabolic disease, there is no such thing as a “cure”. Cancerous environments are a direct result of metabolic dysfunction. Metabolic dysfunction is a condition that is progressive in nature. Therefore, you can reverse cancerous environments through these supportive therapies, as well as making choices that produce a healthy metabolic environment capable of producing ATP energy. There is obviously more to this. Environmental toxin exposures can contribute to unhealthy metabolic environments as well.

Part of our cancer care program is the observational study we are conducting, to better understand how these therapies improve patient outcomes. While there is no silver bullet, we will continue to pursue what is best for our patients based upon the information we have available to us.

What is the observational study? Do I have to participate?

Part of identifying the best treatment modalities for cancer patients, and to better understand who responds and who doesn’t to certain treatments, we are conducting an observational study. Since the study is observational in nature, there are no “placebos” given to participating patients. Additionally, patients are not mandated to comply with any specific aspect of the treatment plan. Lastly, patients do not have to participate if they do not wish to. This will not impact treatment.

The Rebuild Medicine observational study data collection team will be collecting data at specific milestones: six-month, twelve–months, eighteen–months, twenty-four months, three years, four years and five years following your entry into the study. If at any timepoint a patient is lost to follow-up, the team will contact the patient by telephone to obtain updated information on their health status.

Additional Adjunctive Cancer Care Resources

Dr. Pierre Kory substack post about Stage 4 mestastatic lung cancer patients receiving care with repurposed drugs